TY - CHAP
T1 - Role of the Synchronization of Circadian Clock by Meal-Timing in Obesity and Type 2 Diabetes
AU - Jakubowicz, Daniela
AU - Tsameret, Shani
AU - Landau, Zohar
AU - Wainstein, Julio
N1 - Publisher Copyright:
© Springer Nature Switzerland AG 2021.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Obesity and diabetes are increasing worldwide in epidemic proportion. Most alarmingly, is that in the last three decades, no country has successfully succeeded in reducing obesity and diabetesDiabetes rates, therefore “unless the strategies for combating this epidemic are changed,” both obesity and diabetesDiabetes will increase exponentially in the years to come. Most of the metabolic processes involved in glucose and energy metabolismMetabolism, i.e., β-cell secretory function, insulin sensitivityInsulin sensitivity, muscular glucose uptake, and hepatic glucose production, display daily oscillation and are controlled by the circadian clockClock, to anticipate the recurring feeding-fastingFasting cycles and to optimize metabolic efficiency in the appropriate temporal sequence. Growing evidence shows that meal timingMeal timing not aligned with the light/dark cycle, like skipping breakfast, overeatingOvereating at night, or snacking all day, including at hours assigned to sleep, lead to asynchrony and disruption of circadian clock geneClock genes expression and metabolic and appetite disturbances. It has been suggested, that the circadian misalignment and mistimed meals, typical of the modern society exposed to a 7/24 activity schedule, is the underlying cause of the vertiginous rise of obesity and T2D. This review will focus on the recent studies reporting that meal timing aligned with the circadian clock, by shifting most calories and carbohydrates to the early hours of the day, through resetting the synchrony of the circadian clock gene expression, may improve glucose and energy metabolismMetabolism and appetite regulation, resulting in more efficient weight lossWeight loss, better glycemic control and reduced appetite, thereby preventing obesity and hyperglycemic relapse.
AB - Obesity and diabetes are increasing worldwide in epidemic proportion. Most alarmingly, is that in the last three decades, no country has successfully succeeded in reducing obesity and diabetesDiabetes rates, therefore “unless the strategies for combating this epidemic are changed,” both obesity and diabetesDiabetes will increase exponentially in the years to come. Most of the metabolic processes involved in glucose and energy metabolismMetabolism, i.e., β-cell secretory function, insulin sensitivityInsulin sensitivity, muscular glucose uptake, and hepatic glucose production, display daily oscillation and are controlled by the circadian clockClock, to anticipate the recurring feeding-fastingFasting cycles and to optimize metabolic efficiency in the appropriate temporal sequence. Growing evidence shows that meal timingMeal timing not aligned with the light/dark cycle, like skipping breakfast, overeatingOvereating at night, or snacking all day, including at hours assigned to sleep, lead to asynchrony and disruption of circadian clock geneClock genes expression and metabolic and appetite disturbances. It has been suggested, that the circadian misalignment and mistimed meals, typical of the modern society exposed to a 7/24 activity schedule, is the underlying cause of the vertiginous rise of obesity and T2D. This review will focus on the recent studies reporting that meal timing aligned with the circadian clock, by shifting most calories and carbohydrates to the early hours of the day, through resetting the synchrony of the circadian clock gene expression, may improve glucose and energy metabolismMetabolism and appetite regulation, resulting in more efficient weight lossWeight loss, better glycemic control and reduced appetite, thereby preventing obesity and hyperglycemic relapse.
KW - Circadian rhythms
KW - Clock genes
KW - Food-craving
KW - Glycemic oscillations
KW - Weight loss
UR - http://www.scopus.com/inward/record.url?scp=105005877335&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-84763-0_18
DO - 10.1007/978-3-030-84763-0_18
M3 - Chapter
AN - SCOPUS:105005877335
T3 - Advances in Biochemistry in Health and Disease
SP - 337
EP - 351
BT - Advances in Biochemistry in Health and Disease
PB - Springer Nature
ER -